Global Cancer Genome Sequencing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cancer Genome Sequencing market size was valued at US$ million in 2023. With growing demand in downstream market, the Cancer Genome Sequencing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cancer Genome Sequencing market. Cancer Genome Sequencing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Genome Sequencing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Genome Sequencing market.
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
Key Features:
The report on Cancer Genome Sequencing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Genome Sequencing market. It may include historical data, market segmentation by Type (e.g., Second Generation, Third Generation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Genome Sequencing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Genome Sequencing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Genome Sequencing industry. This include advancements in Cancer Genome Sequencing technology, Cancer Genome Sequencing new entrants, Cancer Genome Sequencing new investment, and other innovations that are shaping the future of Cancer Genome Sequencing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Genome Sequencing market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Genome Sequencing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Genome Sequencing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Genome Sequencing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Genome Sequencing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Genome Sequencing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Genome Sequencing market.
Market Segmentation:
Cancer Genome Sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cancer Genome Sequencing market size was valued at US$ million in 2023. With growing demand in downstream market, the Cancer Genome Sequencing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cancer Genome Sequencing market. Cancer Genome Sequencing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Genome Sequencing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Genome Sequencing market.
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
Key Features:
The report on Cancer Genome Sequencing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Genome Sequencing market. It may include historical data, market segmentation by Type (e.g., Second Generation, Third Generation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Genome Sequencing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Genome Sequencing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Genome Sequencing industry. This include advancements in Cancer Genome Sequencing technology, Cancer Genome Sequencing new entrants, Cancer Genome Sequencing new investment, and other innovations that are shaping the future of Cancer Genome Sequencing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Genome Sequencing market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Genome Sequencing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Genome Sequencing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Genome Sequencing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Genome Sequencing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Genome Sequencing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Genome Sequencing market.
Market Segmentation:
Cancer Genome Sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Second Generation
- Third Generation
- Treatment
- Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent Technologies
- GE Healthcare Life Sciences
- Johnson & Johnson
- LI-COR Biosciences
- Abbott Laboratories
- Beckman Coulter
- Bayer
- Hamilton Thorne Biosciences
- Integrated DNA Technologies
- Microchip Biotechnologies
- Myriad Genetics
- Commonwealth Biotechnologies
- ZS Genetics
- Pacific Biosciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Genome Sequencing Market Size 2019-2030
2.1.2 Cancer Genome Sequencing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Genome Sequencing Segment by Type
2.2.1 Second Generation
2.2.2 Third Generation
2.3 Cancer Genome Sequencing Market Size by Type
2.3.1 Cancer Genome Sequencing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
2.4 Cancer Genome Sequencing Segment by Application
2.4.1 Treatment
2.4.2 Research
2.5 Cancer Genome Sequencing Market Size by Application
2.5.1 Cancer Genome Sequencing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
3 CANCER GENOME SEQUENCING MARKET SIZE BY PLAYER
3.1 Cancer Genome Sequencing Market Size Market Share by Players
3.1.1 Global Cancer Genome Sequencing Revenue by Players (2019-2024)
3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Genome Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER GENOME SEQUENCING BY REGIONS
4.1 Cancer Genome Sequencing Market Size by Regions (2019-2024)
4.2 Americas Cancer Genome Sequencing Market Size Growth (2019-2024)
4.3 APAC Cancer Genome Sequencing Market Size Growth (2019-2024)
4.4 Europe Cancer Genome Sequencing Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Genome Sequencing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Genome Sequencing Market Size by Country (2019-2024)
5.2 Americas Cancer Genome Sequencing Market Size by Type (2019-2024)
5.3 Americas Cancer Genome Sequencing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Genome Sequencing Market Size by Region (2019-2024)
6.2 APAC Cancer Genome Sequencing Market Size by Type (2019-2024)
6.3 APAC Cancer Genome Sequencing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Genome Sequencing by Country (2019-2024)
7.2 Europe Cancer Genome Sequencing Market Size by Type (2019-2024)
7.3 Europe Cancer Genome Sequencing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Genome Sequencing by Region (2019-2024)
8.2 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER GENOME SEQUENCING MARKET FORECAST
10.1 Global Cancer Genome Sequencing Forecast by Regions (2025-2030)
10.1.1 Global Cancer Genome Sequencing Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Genome Sequencing Forecast
10.1.3 APAC Cancer Genome Sequencing Forecast
10.1.4 Europe Cancer Genome Sequencing Forecast
10.1.5 Middle East & Africa Cancer Genome Sequencing Forecast
10.2 Americas Cancer Genome Sequencing Forecast by Country (2025-2030)
10.2.1 United States Cancer Genome Sequencing Market Forecast
10.2.2 Canada Cancer Genome Sequencing Market Forecast
10.2.3 Mexico Cancer Genome Sequencing Market Forecast
10.2.4 Brazil Cancer Genome Sequencing Market Forecast
10.3 APAC Cancer Genome Sequencing Forecast by Region (2025-2030)
10.3.1 China Cancer Genome Sequencing Market Forecast
10.3.2 Japan Cancer Genome Sequencing Market Forecast
10.3.3 Korea Cancer Genome Sequencing Market Forecast
10.3.4 Southeast Asia Cancer Genome Sequencing Market Forecast
10.3.5 India Cancer Genome Sequencing Market Forecast
10.3.6 Australia Cancer Genome Sequencing Market Forecast
10.4 Europe Cancer Genome Sequencing Forecast by Country (2025-2030)
10.4.1 Germany Cancer Genome Sequencing Market Forecast
10.4.2 France Cancer Genome Sequencing Market Forecast
10.4.3 UK Cancer Genome Sequencing Market Forecast
10.4.4 Italy Cancer Genome Sequencing Market Forecast
10.4.5 Russia Cancer Genome Sequencing Market Forecast
10.5 Middle East & Africa Cancer Genome Sequencing Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Genome Sequencing Market Forecast
10.5.2 South Africa Cancer Genome Sequencing Market Forecast
10.5.3 Israel Cancer Genome Sequencing Market Forecast
10.5.4 Turkey Cancer Genome Sequencing Market Forecast
10.5.5 GCC Countries Cancer Genome Sequencing Market Forecast
10.6 Global Cancer Genome Sequencing Forecast by Type (2025-2030)
10.7 Global Cancer Genome Sequencing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Cancer Genome Sequencing Product Offered
11.1.3 Agilent Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 GE Healthcare Life Sciences
11.2.1 GE Healthcare Life Sciences Company Information
11.2.2 GE Healthcare Life Sciences Cancer Genome Sequencing Product Offered
11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GE Healthcare Life Sciences Main Business Overview
11.2.5 GE Healthcare Life Sciences Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Cancer Genome Sequencing Product Offered
11.3.3 Johnson & Johnson Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 LI-COR Biosciences
11.4.1 LI-COR Biosciences Company Information
11.4.2 LI-COR Biosciences Cancer Genome Sequencing Product Offered
11.4.3 LI-COR Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 LI-COR Biosciences Main Business Overview
11.4.5 LI-COR Biosciences Latest Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Information
11.5.2 Abbott Laboratories Cancer Genome Sequencing Product Offered
11.5.3 Abbott Laboratories Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Abbott Laboratories Main Business Overview
11.5.5 Abbott Laboratories Latest Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Information
11.6.2 Beckman Coulter Cancer Genome Sequencing Product Offered
11.6.3 Beckman Coulter Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Beckman Coulter Main Business Overview
11.6.5 Beckman Coulter Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Cancer Genome Sequencing Product Offered
11.7.3 Bayer Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Hamilton Thorne Biosciences
11.8.1 Hamilton Thorne Biosciences Company Information
11.8.2 Hamilton Thorne Biosciences Cancer Genome Sequencing Product Offered
11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Hamilton Thorne Biosciences Main Business Overview
11.8.5 Hamilton Thorne Biosciences Latest Developments
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Information
11.9.2 Integrated DNA Technologies Cancer Genome Sequencing Product Offered
11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Integrated DNA Technologies Main Business Overview
11.9.5 Integrated DNA Technologies Latest Developments
11.10 Microchip Biotechnologies
11.10.1 Microchip Biotechnologies Company Information
11.10.2 Microchip Biotechnologies Cancer Genome Sequencing Product Offered
11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Microchip Biotechnologies Main Business Overview
11.10.5 Microchip Biotechnologies Latest Developments
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Information
11.11.2 Myriad Genetics Cancer Genome Sequencing Product Offered
11.11.3 Myriad Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Myriad Genetics Main Business Overview
11.11.5 Myriad Genetics Latest Developments
11.12 Commonwealth Biotechnologies
11.12.1 Commonwealth Biotechnologies Company Information
11.12.2 Commonwealth Biotechnologies Cancer Genome Sequencing Product Offered
11.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Commonwealth Biotechnologies Main Business Overview
11.12.5 Commonwealth Biotechnologies Latest Developments
11.13 ZS Genetics
11.13.1 ZS Genetics Company Information
11.13.2 ZS Genetics Cancer Genome Sequencing Product Offered
11.13.3 ZS Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 ZS Genetics Main Business Overview
11.13.5 ZS Genetics Latest Developments
11.14 Pacific Biosciences
11.14.1 Pacific Biosciences Company Information
11.14.2 Pacific Biosciences Cancer Genome Sequencing Product Offered
11.14.3 Pacific Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Pacific Biosciences Main Business Overview
11.14.5 Pacific Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Genome Sequencing Market Size 2019-2030
2.1.2 Cancer Genome Sequencing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Genome Sequencing Segment by Type
2.2.1 Second Generation
2.2.2 Third Generation
2.3 Cancer Genome Sequencing Market Size by Type
2.3.1 Cancer Genome Sequencing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
2.4 Cancer Genome Sequencing Segment by Application
2.4.1 Treatment
2.4.2 Research
2.5 Cancer Genome Sequencing Market Size by Application
2.5.1 Cancer Genome Sequencing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
3 CANCER GENOME SEQUENCING MARKET SIZE BY PLAYER
3.1 Cancer Genome Sequencing Market Size Market Share by Players
3.1.1 Global Cancer Genome Sequencing Revenue by Players (2019-2024)
3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Genome Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER GENOME SEQUENCING BY REGIONS
4.1 Cancer Genome Sequencing Market Size by Regions (2019-2024)
4.2 Americas Cancer Genome Sequencing Market Size Growth (2019-2024)
4.3 APAC Cancer Genome Sequencing Market Size Growth (2019-2024)
4.4 Europe Cancer Genome Sequencing Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Genome Sequencing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Genome Sequencing Market Size by Country (2019-2024)
5.2 Americas Cancer Genome Sequencing Market Size by Type (2019-2024)
5.3 Americas Cancer Genome Sequencing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Genome Sequencing Market Size by Region (2019-2024)
6.2 APAC Cancer Genome Sequencing Market Size by Type (2019-2024)
6.3 APAC Cancer Genome Sequencing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Genome Sequencing by Country (2019-2024)
7.2 Europe Cancer Genome Sequencing Market Size by Type (2019-2024)
7.3 Europe Cancer Genome Sequencing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Genome Sequencing by Region (2019-2024)
8.2 Middle East & Africa Cancer Genome Sequencing Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Genome Sequencing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER GENOME SEQUENCING MARKET FORECAST
10.1 Global Cancer Genome Sequencing Forecast by Regions (2025-2030)
10.1.1 Global Cancer Genome Sequencing Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Genome Sequencing Forecast
10.1.3 APAC Cancer Genome Sequencing Forecast
10.1.4 Europe Cancer Genome Sequencing Forecast
10.1.5 Middle East & Africa Cancer Genome Sequencing Forecast
10.2 Americas Cancer Genome Sequencing Forecast by Country (2025-2030)
10.2.1 United States Cancer Genome Sequencing Market Forecast
10.2.2 Canada Cancer Genome Sequencing Market Forecast
10.2.3 Mexico Cancer Genome Sequencing Market Forecast
10.2.4 Brazil Cancer Genome Sequencing Market Forecast
10.3 APAC Cancer Genome Sequencing Forecast by Region (2025-2030)
10.3.1 China Cancer Genome Sequencing Market Forecast
10.3.2 Japan Cancer Genome Sequencing Market Forecast
10.3.3 Korea Cancer Genome Sequencing Market Forecast
10.3.4 Southeast Asia Cancer Genome Sequencing Market Forecast
10.3.5 India Cancer Genome Sequencing Market Forecast
10.3.6 Australia Cancer Genome Sequencing Market Forecast
10.4 Europe Cancer Genome Sequencing Forecast by Country (2025-2030)
10.4.1 Germany Cancer Genome Sequencing Market Forecast
10.4.2 France Cancer Genome Sequencing Market Forecast
10.4.3 UK Cancer Genome Sequencing Market Forecast
10.4.4 Italy Cancer Genome Sequencing Market Forecast
10.4.5 Russia Cancer Genome Sequencing Market Forecast
10.5 Middle East & Africa Cancer Genome Sequencing Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Genome Sequencing Market Forecast
10.5.2 South Africa Cancer Genome Sequencing Market Forecast
10.5.3 Israel Cancer Genome Sequencing Market Forecast
10.5.4 Turkey Cancer Genome Sequencing Market Forecast
10.5.5 GCC Countries Cancer Genome Sequencing Market Forecast
10.6 Global Cancer Genome Sequencing Forecast by Type (2025-2030)
10.7 Global Cancer Genome Sequencing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Cancer Genome Sequencing Product Offered
11.1.3 Agilent Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 GE Healthcare Life Sciences
11.2.1 GE Healthcare Life Sciences Company Information
11.2.2 GE Healthcare Life Sciences Cancer Genome Sequencing Product Offered
11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GE Healthcare Life Sciences Main Business Overview
11.2.5 GE Healthcare Life Sciences Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Cancer Genome Sequencing Product Offered
11.3.3 Johnson & Johnson Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 LI-COR Biosciences
11.4.1 LI-COR Biosciences Company Information
11.4.2 LI-COR Biosciences Cancer Genome Sequencing Product Offered
11.4.3 LI-COR Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 LI-COR Biosciences Main Business Overview
11.4.5 LI-COR Biosciences Latest Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Information
11.5.2 Abbott Laboratories Cancer Genome Sequencing Product Offered
11.5.3 Abbott Laboratories Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Abbott Laboratories Main Business Overview
11.5.5 Abbott Laboratories Latest Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Information
11.6.2 Beckman Coulter Cancer Genome Sequencing Product Offered
11.6.3 Beckman Coulter Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Beckman Coulter Main Business Overview
11.6.5 Beckman Coulter Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Cancer Genome Sequencing Product Offered
11.7.3 Bayer Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Hamilton Thorne Biosciences
11.8.1 Hamilton Thorne Biosciences Company Information
11.8.2 Hamilton Thorne Biosciences Cancer Genome Sequencing Product Offered
11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Hamilton Thorne Biosciences Main Business Overview
11.8.5 Hamilton Thorne Biosciences Latest Developments
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Information
11.9.2 Integrated DNA Technologies Cancer Genome Sequencing Product Offered
11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Integrated DNA Technologies Main Business Overview
11.9.5 Integrated DNA Technologies Latest Developments
11.10 Microchip Biotechnologies
11.10.1 Microchip Biotechnologies Company Information
11.10.2 Microchip Biotechnologies Cancer Genome Sequencing Product Offered
11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Microchip Biotechnologies Main Business Overview
11.10.5 Microchip Biotechnologies Latest Developments
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Information
11.11.2 Myriad Genetics Cancer Genome Sequencing Product Offered
11.11.3 Myriad Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Myriad Genetics Main Business Overview
11.11.5 Myriad Genetics Latest Developments
11.12 Commonwealth Biotechnologies
11.12.1 Commonwealth Biotechnologies Company Information
11.12.2 Commonwealth Biotechnologies Cancer Genome Sequencing Product Offered
11.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Commonwealth Biotechnologies Main Business Overview
11.12.5 Commonwealth Biotechnologies Latest Developments
11.13 ZS Genetics
11.13.1 ZS Genetics Company Information
11.13.2 ZS Genetics Cancer Genome Sequencing Product Offered
11.13.3 ZS Genetics Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 ZS Genetics Main Business Overview
11.13.5 ZS Genetics Latest Developments
11.14 Pacific Biosciences
11.14.1 Pacific Biosciences Company Information
11.14.2 Pacific Biosciences Cancer Genome Sequencing Product Offered
11.14.3 Pacific Biosciences Cancer Genome Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Pacific Biosciences Main Business Overview
11.14.5 Pacific Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cancer Genome Sequencing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Second Generation
Table 3. Major Players of Third Generation
Table 4. Cancer Genome Sequencing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 7. Cancer Genome Sequencing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 10. Global Cancer Genome Sequencing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Cancer Genome Sequencing Revenue Market Share by Player (2019-2024)
Table 12. Cancer Genome Sequencing Key Players Head office and Products Offered
Table 13. Cancer Genome Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Cancer Genome Sequencing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Cancer Genome Sequencing Market Size Market Share by Regions (2019-2024)
Table 18. Global Cancer Genome Sequencing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Cancer Genome Sequencing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Cancer Genome Sequencing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Cancer Genome Sequencing Market Size Market Share by Country (2019-2024)
Table 22. Americas Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 24. Americas Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 26. APAC Cancer Genome Sequencing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Cancer Genome Sequencing Market Size Market Share by Region (2019-2024)
Table 28. APAC Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 30. APAC Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 32. Europe Cancer Genome Sequencing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Cancer Genome Sequencing Market Size Market Share by Country (2019-2024)
Table 34. Europe Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 36. Europe Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Cancer Genome Sequencing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Cancer Genome Sequencing
Table 45. Key Market Challenges & Risks of Cancer Genome Sequencing
Table 46. Key Industry Trends of Cancer Genome Sequencing
Table 47. Global Cancer Genome Sequencing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Cancer Genome Sequencing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Cancer Genome Sequencing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Cancer Genome Sequencing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Agilent Technologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 52. Agilent Technologies Cancer Genome Sequencing Product Offered
Table 53. Agilent Technologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Agilent Technologies Main Business
Table 55. Agilent Technologies Latest Developments
Table 56. GE Healthcare Life Sciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 57. GE Healthcare Life Sciences Cancer Genome Sequencing Product Offered
Table 58. GE Healthcare Life Sciences Main Business
Table 59. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GE Healthcare Life Sciences Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 62. Johnson & Johnson Cancer Genome Sequencing Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. LI-COR Biosciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 67. LI-COR Biosciences Cancer Genome Sequencing Product Offered
Table 68. LI-COR Biosciences Main Business
Table 69. LI-COR Biosciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. LI-COR Biosciences Latest Developments
Table 71. Abbott Laboratories Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 72. Abbott Laboratories Cancer Genome Sequencing Product Offered
Table 73. Abbott Laboratories Main Business
Table 74. Abbott Laboratories Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Abbott Laboratories Latest Developments
Table 76. Beckman Coulter Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 77. Beckman Coulter Cancer Genome Sequencing Product Offered
Table 78. Beckman Coulter Main Business
Table 79. Beckman Coulter Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Beckman Coulter Latest Developments
Table 81. Bayer Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 82. Bayer Cancer Genome Sequencing Product Offered
Table 83. Bayer Main Business
Table 84. Bayer Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Bayer Latest Developments
Table 86. Hamilton Thorne Biosciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 87. Hamilton Thorne Biosciences Cancer Genome Sequencing Product Offered
Table 88. Hamilton Thorne Biosciences Main Business
Table 89. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hamilton Thorne Biosciences Latest Developments
Table 91. Integrated DNA Technologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 92. Integrated DNA Technologies Cancer Genome Sequencing Product Offered
Table 93. Integrated DNA Technologies Main Business
Table 94. Integrated DNA Technologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Integrated DNA Technologies Latest Developments
Table 96. Microchip Biotechnologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 97. Microchip Biotechnologies Cancer Genome Sequencing Product Offered
Table 98. Microchip Biotechnologies Main Business
Table 99. Microchip Biotechnologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Microchip Biotechnologies Latest Developments
Table 101. Myriad Genetics Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 102. Myriad Genetics Cancer Genome Sequencing Product Offered
Table 103. Myriad Genetics Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Myriad Genetics Main Business
Table 105. Myriad Genetics Latest Developments
Table 106. Commonwealth Biotechnologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 107. Commonwealth Biotechnologies Cancer Genome Sequencing Product Offered
Table 108. Commonwealth Biotechnologies Main Business
Table 109. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Commonwealth Biotechnologies Latest Developments
Table 111. ZS Genetics Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 112. ZS Genetics Cancer Genome Sequencing Product Offered
Table 113. ZS Genetics Main Business
Table 114. ZS Genetics Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. ZS Genetics Latest Developments
Table 116. Pacific Biosciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 117. Pacific Biosciences Cancer Genome Sequencing Product Offered
Table 118. Pacific Biosciences Main Business
Table 119. Pacific Biosciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Pacific Biosciences Latest Developments
Table 1. Cancer Genome Sequencing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Second Generation
Table 3. Major Players of Third Generation
Table 4. Cancer Genome Sequencing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 7. Cancer Genome Sequencing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 10. Global Cancer Genome Sequencing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Cancer Genome Sequencing Revenue Market Share by Player (2019-2024)
Table 12. Cancer Genome Sequencing Key Players Head office and Products Offered
Table 13. Cancer Genome Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Cancer Genome Sequencing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Cancer Genome Sequencing Market Size Market Share by Regions (2019-2024)
Table 18. Global Cancer Genome Sequencing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Cancer Genome Sequencing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Cancer Genome Sequencing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Cancer Genome Sequencing Market Size Market Share by Country (2019-2024)
Table 22. Americas Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 24. Americas Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 26. APAC Cancer Genome Sequencing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Cancer Genome Sequencing Market Size Market Share by Region (2019-2024)
Table 28. APAC Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 30. APAC Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 32. Europe Cancer Genome Sequencing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Cancer Genome Sequencing Market Size Market Share by Country (2019-2024)
Table 34. Europe Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 36. Europe Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Cancer Genome Sequencing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Cancer Genome Sequencing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Cancer Genome Sequencing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Cancer Genome Sequencing
Table 45. Key Market Challenges & Risks of Cancer Genome Sequencing
Table 46. Key Industry Trends of Cancer Genome Sequencing
Table 47. Global Cancer Genome Sequencing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Cancer Genome Sequencing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Cancer Genome Sequencing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Cancer Genome Sequencing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Agilent Technologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 52. Agilent Technologies Cancer Genome Sequencing Product Offered
Table 53. Agilent Technologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Agilent Technologies Main Business
Table 55. Agilent Technologies Latest Developments
Table 56. GE Healthcare Life Sciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 57. GE Healthcare Life Sciences Cancer Genome Sequencing Product Offered
Table 58. GE Healthcare Life Sciences Main Business
Table 59. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GE Healthcare Life Sciences Latest Developments
Table 61. Johnson & Johnson Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 62. Johnson & Johnson Cancer Genome Sequencing Product Offered
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Latest Developments
Table 66. LI-COR Biosciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 67. LI-COR Biosciences Cancer Genome Sequencing Product Offered
Table 68. LI-COR Biosciences Main Business
Table 69. LI-COR Biosciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. LI-COR Biosciences Latest Developments
Table 71. Abbott Laboratories Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 72. Abbott Laboratories Cancer Genome Sequencing Product Offered
Table 73. Abbott Laboratories Main Business
Table 74. Abbott Laboratories Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Abbott Laboratories Latest Developments
Table 76. Beckman Coulter Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 77. Beckman Coulter Cancer Genome Sequencing Product Offered
Table 78. Beckman Coulter Main Business
Table 79. Beckman Coulter Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Beckman Coulter Latest Developments
Table 81. Bayer Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 82. Bayer Cancer Genome Sequencing Product Offered
Table 83. Bayer Main Business
Table 84. Bayer Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Bayer Latest Developments
Table 86. Hamilton Thorne Biosciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 87. Hamilton Thorne Biosciences Cancer Genome Sequencing Product Offered
Table 88. Hamilton Thorne Biosciences Main Business
Table 89. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hamilton Thorne Biosciences Latest Developments
Table 91. Integrated DNA Technologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 92. Integrated DNA Technologies Cancer Genome Sequencing Product Offered
Table 93. Integrated DNA Technologies Main Business
Table 94. Integrated DNA Technologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Integrated DNA Technologies Latest Developments
Table 96. Microchip Biotechnologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 97. Microchip Biotechnologies Cancer Genome Sequencing Product Offered
Table 98. Microchip Biotechnologies Main Business
Table 99. Microchip Biotechnologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Microchip Biotechnologies Latest Developments
Table 101. Myriad Genetics Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 102. Myriad Genetics Cancer Genome Sequencing Product Offered
Table 103. Myriad Genetics Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Myriad Genetics Main Business
Table 105. Myriad Genetics Latest Developments
Table 106. Commonwealth Biotechnologies Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 107. Commonwealth Biotechnologies Cancer Genome Sequencing Product Offered
Table 108. Commonwealth Biotechnologies Main Business
Table 109. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Commonwealth Biotechnologies Latest Developments
Table 111. ZS Genetics Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 112. ZS Genetics Cancer Genome Sequencing Product Offered
Table 113. ZS Genetics Main Business
Table 114. ZS Genetics Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. ZS Genetics Latest Developments
Table 116. Pacific Biosciences Details, Company Type, Cancer Genome Sequencing Area Served and Its Competitors
Table 117. Pacific Biosciences Cancer Genome Sequencing Product Offered
Table 118. Pacific Biosciences Main Business
Table 119. Pacific Biosciences Cancer Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Pacific Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Cancer Genome Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Genome Sequencing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Genome Sequencing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Genome Sequencing Sales Market Share by Country/Region (2023)
Figure 8. Cancer Genome Sequencing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Genome Sequencing Market Size Market Share by Type in 2023
Figure 10. Cancer Genome Sequencing in Treatment
Figure 11. Global Cancer Genome Sequencing Market: Treatment (2019-2024) & ($ Millions)
Figure 12. Cancer Genome Sequencing in Research
Figure 13. Global Cancer Genome Sequencing Market: Research (2019-2024) & ($ Millions)
Figure 14. Global Cancer Genome Sequencing Market Size Market Share by Application in 2023
Figure 15. Global Cancer Genome Sequencing Revenue Market Share by Player in 2023
Figure 16. Global Cancer Genome Sequencing Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 18. APAC Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 19. Europe Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 21. Americas Cancer Genome Sequencing Value Market Share by Country in 2023
Figure 22. United States Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Cancer Genome Sequencing Market Size Market Share by Region in 2023
Figure 27. APAC Cancer Genome Sequencing Market Size Market Share by Type in 2023
Figure 28. APAC Cancer Genome Sequencing Market Size Market Share by Application in 2023
Figure 29. China Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Cancer Genome Sequencing Market Size Market Share by Country in 2023
Figure 36. Europe Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 52. APAC Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 53. Europe Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 55. United States Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 56. Canada Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 59. China Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 60. Japan Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 61. Korea Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 63. India Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 64. Australia Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 65. Germany Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 66. France Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 67. UK Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 68. Italy Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 69. Russia Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 70. Spain Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 73. Israel Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 76. Global Cancer Genome Sequencing Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Cancer Genome Sequencing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Cancer Genome Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Genome Sequencing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Genome Sequencing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Genome Sequencing Sales Market Share by Country/Region (2023)
Figure 8. Cancer Genome Sequencing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Genome Sequencing Market Size Market Share by Type in 2023
Figure 10. Cancer Genome Sequencing in Treatment
Figure 11. Global Cancer Genome Sequencing Market: Treatment (2019-2024) & ($ Millions)
Figure 12. Cancer Genome Sequencing in Research
Figure 13. Global Cancer Genome Sequencing Market: Research (2019-2024) & ($ Millions)
Figure 14. Global Cancer Genome Sequencing Market Size Market Share by Application in 2023
Figure 15. Global Cancer Genome Sequencing Revenue Market Share by Player in 2023
Figure 16. Global Cancer Genome Sequencing Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 18. APAC Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 19. Europe Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Cancer Genome Sequencing Market Size 2019-2024 ($ Millions)
Figure 21. Americas Cancer Genome Sequencing Value Market Share by Country in 2023
Figure 22. United States Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Cancer Genome Sequencing Market Size Market Share by Region in 2023
Figure 27. APAC Cancer Genome Sequencing Market Size Market Share by Type in 2023
Figure 28. APAC Cancer Genome Sequencing Market Size Market Share by Application in 2023
Figure 29. China Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Cancer Genome Sequencing Market Size Market Share by Country in 2023
Figure 36. Europe Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Cancer Genome Sequencing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Cancer Genome Sequencing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 52. APAC Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 53. Europe Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 55. United States Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 56. Canada Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 59. China Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 60. Japan Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 61. Korea Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 63. India Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 64. Australia Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 65. Germany Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 66. France Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 67. UK Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 68. Italy Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 69. Russia Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 70. Spain Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 73. Israel Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Cancer Genome Sequencing Market Size 2025-2030 ($ Millions)
Figure 76. Global Cancer Genome Sequencing Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Cancer Genome Sequencing Market Size Market Share Forecast by Application (2025-2030)
